CEACAM5 and neoplasm: These six patients met criteria for resensitization with one or more of the following: a (1) decline in the tumor-associated marker carcinoembryonic antigen (CEA); (2) improvement in clinical performance status; and/or (3) PR/SD on positron emission tomography (PET) or computer tomography (CT).